• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Xanthine oxidase inhibitors in heart failure: where do we go from here?

作者信息

Tamariz Leonardo, Hare Joshua M

机构信息

From Department of Medicine (L.T., J.M.H.) and Interdisciplinary Stem Cell Institute (J.M.H.), University of Miami Miller School of Medicine, FL; and Veterans Affairs Medical Center, Miami, FL (L.T.).

出版信息

Circulation. 2015 May 19;131(20):1741-4. doi: 10.1161/CIRCULATIONAHA.115.016379. Epub 2015 Apr 14.

DOI:10.1161/CIRCULATIONAHA.115.016379
PMID:25986446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4438774/
Abstract
摘要

相似文献

1
Xanthine oxidase inhibitors in heart failure: where do we go from here?心力衰竭中的黄嘌呤氧化酶抑制剂：我们从这里何去何从？
Circulation. 2015 May 19;131(20):1741-4. doi: 10.1161/CIRCULATIONAHA.115.016379. Epub 2015 Apr 14.
2
The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.黄嘌呤氧化酶抑制剂对慢性心力衰竭合并高尿酸血症患者的影响：托匹司他与别嘌醇对比的前瞻性随机对照临床试验——研究方案
Clin Exp Nephrol. 2018 Dec;22(6):1379-1386. doi: 10.1007/s10157-018-1599-6. Epub 2018 Jun 18.
3
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.黄嘌呤氧化酶抑制对高尿酸血症心力衰竭患者的影响：黄嘌呤氧化酶抑制治疗高尿酸血症心力衰竭患者（EXACT-HF）研究
Circulation. 2015 May 19;131(20):1763-71. doi: 10.1161/CIRCULATIONAHA.114.014536. Epub 2015 Apr 14.
4
Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study.黄嘌呤氧化酶抑制用于高尿酸血症心力衰竭患者：EXACT-HF研究的设计与原理
Circ Heart Fail. 2013 Jul;6(4):862-8. doi: 10.1161/CIRCHEARTFAILURE.113.000394.
5
Xanthine oxidase inhibitors: an emerging class of drugs for heart failure.黄嘌呤氧化酶抑制剂：一类用于治疗心力衰竭的新兴药物。
Eur Heart J. 2005 Aug;26(15):1458-60. doi: 10.1093/eurheartj/ehi321. Epub 2005 May 25.
6
Hyperuricemia and adverse outcomes in cardiovascular disease: potential for therapeutic intervention.高尿酸血症与心血管疾病的不良结局：治疗干预的潜力
Am J Cardiovasc Drugs. 2003;3(5):309-14. doi: 10.2165/00129784-200303050-00001.
7
Management of hyperuricemia with rasburicase review.拉布立酶治疗高尿酸血症的综述
Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1431-40. doi: 10.1081/NCN-200027656.
8
[Secondary hyperuricemia in hematologic disease].[血液系统疾病中的继发性高尿酸血症]
Nihon Rinsho. 2003 Jan;61 Suppl 1:299-303.
9
Febuxostat--treatment for hyperuricemia and gout?非布司他——用于治疗高尿酸血症和痛风？
N Engl J Med. 2005 Dec 8;353(23):2505-7. doi: 10.1056/NEJMe058247.
10
Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.非布司他：一种选择性黄嘌呤氧化酶/黄嘌呤脱氢酶抑制剂，用于治疗成人痛风患者的高尿酸血症。
Clin Ther. 2009 Nov;31(11):2503-18. doi: 10.1016/j.clinthera.2009.11.033.

引用本文的文献

1
Cardiac autoantibodies promote a fibrotic transcriptome and reduced ventricular recovery in human myocarditis.心脏自身抗体可促进人类心肌炎中的纤维化转录组并降低心室恢复能力。
Front Immunol. 2025 Mar 20;16:1500909. doi: 10.3389/fimmu.2025.1500909. eCollection 2025.
2
In Silico Prediction of Maize microRNA as a Xanthine Oxidase Inhibitor: A New Approach to Treating Hyperuricemia Patients.玉米微小RNA作为黄嘌呤氧化酶抑制剂的计算机模拟预测：治疗高尿酸血症患者的新方法
Noncoding RNA. 2025 Jan 15;11(1):6. doi: 10.3390/ncrna11010006.
3
Gender differences in the prognostic impact of uric acid in patients with heart failure and preserved ejection fraction.射血分数保留的心力衰竭患者中尿酸预后影响的性别差异。
BMC Cardiovasc Disord. 2025 Jan 17;25(1):29. doi: 10.1186/s12872-025-04481-6.
4
Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease.比较糖尿病合并慢性肾脏病患者使用非布司他和别嘌醇的心血管风险。
Med Sci Monit. 2024 Jun 12;30:e944314. doi: 10.12659/MSM.944314.
5
Influence of xanthine oxidase inhibitors on all-cause mortality in adults: a systematic review and meta-analysis.黄嘌呤氧化酶抑制剂对成年人全因死亡率的影响：系统评价和荟萃分析。
Cardiol J. 2024;31(3):479-487. doi: 10.5603/cj.97807. Epub 2024 May 21.
6
Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study.超重和肥胖日本男性循环中黄嘌呤氧化还原酶活性与心脏代谢风险标志物的关联：一项横断面初步研究
J Clin Biochem Nutr. 2022 Sep;71(2):122-128. doi: 10.3164/jcbn.21-118. Epub 2022 Apr 12.
7
The Oxidative Balance Orchestrates the Main Keystones of the Functional Activity of Cardiomyocytes.氧化平衡调控心肌细胞功能活动的主要关键。
Oxid Med Cell Longev. 2022 Jan 10;2022:7714542. doi: 10.1155/2022/7714542. eCollection 2022.
8
Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets.人类心力衰竭中的炎症：主要介质与治疗靶点
Front Physiol. 2021 Oct 11;12:746494. doi: 10.3389/fphys.2021.746494. eCollection 2021.
9
Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures.左心辅助装置植入时二尖瓣反流严重程度与独特的心肌转录组特征相关。
J Thorac Cardiovasc Surg. 2023 Jul;166(1):141-152.e1. doi: 10.1016/j.jtcvs.2021.08.061. Epub 2021 Sep 14.
10
From Prevention to Disease Perturbations: A Multi-Omic Assessment of Exercise and Myocardial Infarctions.从预防到疾病扰动：运动与心肌梗死的多组学评估
Biomolecules. 2020 Dec 30;11(1):40. doi: 10.3390/biom11010040.

本文引用的文献

1
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.黄嘌呤氧化酶抑制对高尿酸血症心力衰竭患者的影响：黄嘌呤氧化酶抑制治疗高尿酸血症心力衰竭患者（EXACT-HF）研究
Circulation. 2015 May 19;131(20):1763-71. doi: 10.1161/CIRCULATIONAHA.114.014536. Epub 2015 Apr 14.
2
The war against heart failure: the Lancet lecture.与心力衰竭作斗争：柳叶刀演讲。
Lancet. 2015 Feb 28;385(9970):812-24. doi: 10.1016/S0140-6736(14)61889-4. Epub 2014 Nov 16.
3
Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis.血清尿酸与心房颤动之间的关联：一项系统评价和荟萃分析。
Heart Rhythm. 2014 Jul;11(7):1102-8. doi: 10.1016/j.hrthm.2014.04.003. Epub 2014 Apr 5.
4
Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.尿酸水平变化和别嘌醇在慢性心力衰竭中的应用：与改善生存的关系。
J Card Fail. 2012 Sep;18(9):694-701. doi: 10.1016/j.cardfail.2012.06.528. Epub 2012 Aug 3.
5
Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts.别嘌醇可急性增加衰竭人心肌中三磷酸腺苷的能量传递。
J Am Coll Cardiol. 2012 Feb 28;59(9):802-8. doi: 10.1016/j.jacc.2011.10.895.
6
Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study).血清尿酸与心房颤动事件的相关性（来自社区动脉粥样硬化风险研究[ARIC]）。
Am J Cardiol. 2011 Nov 1;108(9):1272-6. doi: 10.1016/j.amjcard.2011.06.043. Epub 2011 Aug 17.
7
Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis.尿酸作为心力衰竭全因死亡率的预测指标：一项荟萃分析。
Congest Heart Fail. 2011 Jan-Feb;17(1):25-30. doi: 10.1111/j.1751-7133.2011.00200.x. Epub 2011 Jan 27.
8
Allopurinol and global left myocardial function in heart failure patients.别嘌醇与心力衰竭患者的整体左心室心肌功能
J Cardiovasc Dis Res. 2010 Oct;1(4):191-5. doi: 10.4103/0975-3583.74262.
9
Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters.黄嘌呤氧化酶抑制剂和他汀类药物在慢性心力衰竭中的作用：对血管和功能参数的影响。
J Heart Lung Transplant. 2011 Apr;30(4):408-13. doi: 10.1016/j.healun.2010.10.003. Epub 2010 Dec 8.
10
Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice.神经元型一氧化氮合酶可保护小鼠免受心肌梗死诱导的室性心律失常和死亡。
Circulation. 2009 Oct 6;120(14):1345-54. doi: 10.1161/CIRCULATIONAHA.108.846402. Epub 2009 Sep 21.